Charles N York Ii Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

Charles N York Ii is COO, CFO AND SECRETARY of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 224,868 shares of DAWN, which is worth approximately $3.64 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 2,675 shares (Common Stock) at a price of $16.08 per share, resulting in proceeds of $43,013. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 225K

19.04% 3M change

15.08% 12M change

Total Value Held $3.64 Million

Charles N York II Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2024	SELL Open market or private sale	$43,013 $16.08 p/Share	2,675 Reduced 1.18%	224,868 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	10,250 Added 4.31%	227,543 Common Stock
May 03 2024	SELL Open market or private sale	$144,192 $17.85 p/Share	8,078 Reduced 3.58%	217,293 Common Stock
May 02 2024	SELL Open market or private sale	$3,579 $17.9 p/Share	200 Reduced 0.09%	225,371 Common Stock
May 01 2024	SELL Open market or private sale	$933,553 $17.89 p/Share	52,183 Reduced 18.79%	225,571 Common Stock
Feb 16 2024	SELL Open market or private sale	$40,656 $15.25 p/Share	2,666 Reduced 0.95%	277,754 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	10,250 Added 3.53%	280,420 Common Stock

Nov 16 2023	SELL Open market or private sale	$11,175 $11.69 p/Share	956 Reduced 0.35%	270,170 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	-	3,625 Added 1.32%	271,126 Common Stock
Aug 17 2023	SELL Open market or private sale	$12,778 $13.86 p/Share	922 Reduced 0.34%	267,501 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	-	3,625 Added 1.33%	268,423 Common Stock
May 16 2023	SELL Open market or private sale	$12,529 $13.12 p/Share	955 Reduced 0.36%	264,798 Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	-	3,625 Added 1.35%	265,753 Common Stock
Feb 17 2023	SELL Open market or private sale	$187,821 $20.03 p/Share	9,377 Reduced 3.45%	262,128 Common Stock
Feb 16 2023	SELL Open market or private sale	$18,200 $19.57 p/Share	930 Reduced 0.34%	271,505 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	3,625 Added 1.31%	272,435 Common Stock
Jan 20 2023	SELL Open market or private sale	$227,500 $22.75 p/Share	10,000 Reduced 3.59%	268,810 Common Stock
Dec 20 2022	SELL Open market or private sale	$200,700 $20.07 p/Share	10,000 Reduced 3.49%	276,497 Common Stock
Nov 21 2022	SELL Open market or private sale	$210,700 $21.07 p/Share	10,000 Reduced 3.37%	286,497 Common Stock
Nov 16 2022	SELL Open market or private sale	$9,227 $21.46 p/Share	430 Reduced 0.14%	296,497 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	-	1,375 Added 0.46%	295,776 Common Stock
Nov 01 2022	SELL Open market or private sale	$200,300 $20.03 p/Share	10,000 Reduced 3.29%	294,401 Common Stock
Oct 03 2022	SELL Open market or private sale	$200,500 $20.05 p/Share	10,000 Reduced 3.18%	304,401 Common Stock
Sep 01 2022	SELL Open market or private sale	$234,800 $23.48 p/Share	10,000 Reduced 3.08%	314,401 Common Stock
Aug 16 2022	SELL Open market or private sale	$26,474 $24.31 p/Share	1,089 Reduced 0.33%	324,401 Common Stock

CNY

Charles N York Ii

COO, CFO AND SECRETARY

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Value

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN

Account